Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06414993 · ClinicalTrials.gov registry record · NA
Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults
A NA study of Polysubstance Drug Use (Indiscriminate Drug Use), sponsored by Chestnut Health Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 8
- Study locations
NCT06414993 is a NA study of Polysubstance Drug Use (Indiscriminate Drug Use) that is actively recruiting participants, run by Chestnut Health Systems. The registered enrollment target is 48 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT06414993, a NA study of Polysubstance Drug Use (Indiscriminate Drug Use), is actively recruiting participants, sponsored by Chestnut Health Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 8
- Study locations
Study Summary
Emerging adults (EAs; aged 18-26) are the highest-risk population for poly-substance use (misuse of more than one drug), compared to all other age groups and are the least-served population for substance use services. The overarching purpose of this pilot study is to assess whether an innovative services package, Launch, can reasonably work (is feasible) and whether providers and participants like it (acceptability). Launch works with both EAs and a supportive parent (or parental figure) and delivers peer recovery support services (PRSS) to EAs while helping parents use an effective, evidence-based program called contingency management, adapted for EAs, at home with their EA child. This study will also lay the groundwork for a future large-scale trial of Launch services.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management for Emerging Adults (CM-EA)
- BEHAVIORAL Standard Peer Recovery Support Services (PRSS) +Vocational/Educational (V/E) Skill Building services
Study Locations (8)
Illinois
- A New Horizon - Bloomington
- Chestnut Health Systems - Granite City
- Take Action Today - West Frankfort
Georgia
- Rising Sun Recovery - Hiram
Indiana
- Wabash Valley Recovery Center - Terre Haute
Missouri
- Chestnut Health Systems - Hillsboro
Oregon
- Chestnut Health Systems - Eugene
Tennessee
- WeCare Hawkins - Rogersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06414993
The ClinicalTrials.gov registry entry for NCT06414993 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chestnut Health Systems, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Polysubstance Drug Use (Indiscriminate Drug Use) appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management for Emerging Adults (CM-EA) is the first listed.
NCT06414993 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Illinois, Georgia, Indiana.
Frequently Asked Questions
What is clinical trial NCT06414993 about?
NCT06414993 is a clinical study titled "Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults". Emerging adults (EAs; aged 18-26) are the highest-risk population for poly-substance use (misuse of more than one drug), compared to all other age groups and are the least-served population for substance use services. The overarching purpose of this pilot study is to assess whether an innovative ser...
What is the current status of trial NCT06414993?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2024-06-07. Estimated completion is 2026-09-01.
What conditions does trial NCT06414993 study?
This clinical trial studies the following conditions: Polysubstance Drug Use (Indiscriminate Drug Use).
What interventions are being tested in trial NCT06414993?
The interventions under investigation include: Contingency Management for Emerging Adults (CM-EA) (BEHAVIORAL), Standard Peer Recovery Support Services (PRSS) +Vocational/Educational (V/E) Skill Building services (BEHAVIORAL).
Who is sponsoring clinical trial NCT06414993?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06414993 being conducted?
This trial has 8 study locations across Georgia, Illinois, Indiana, Missouri, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polysubstance Drug Use (Indiscriminate Drug Use)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.